BRPI0510367A - métodos e composições para o tratamento de doenças policìsticas - Google Patents
métodos e composições para o tratamento de doenças policìsticasInfo
- Publication number
- BRPI0510367A BRPI0510367A BRPI0510367-3A BRPI0510367A BRPI0510367A BR PI0510367 A BRPI0510367 A BR PI0510367A BR PI0510367 A BRPI0510367 A BR PI0510367A BR PI0510367 A BRPI0510367 A BR PI0510367A
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- compositions
- gene
- treatment
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
MéTODOS E COMPOSIçõES PARA O TRATAMENTO DE DOENçAS POLICìSTICAS. A presente invenção refere-se a composições e métodos para diagnosticar e tratar distúrbios policísticos através da inibição da atividade biológica de um gene agora relacionado com o aparecimento desse distúrbio. Somente a título de ilustração, o gene do Fator de Crescimento do Tecido Conectivo (CTGF) é um exemplo de tal gene. Também são providos por esta invenção composições e métodos para tratar ou aliviar lesões císticas anormais e doenças associadas com a formação de cistos no tecido. Os métodos e as composições tratam e aliviam a formação patológica de cistos nos tecidos através da inibição ou do aumento da expressão do gene, ou da atividade biológica do seu produto da sua expressão do gene ou do seu receptor.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56667004P | 2004-04-29 | 2004-04-29 | |
US59038504P | 2004-07-22 | 2004-07-22 | |
PCT/US2005/014982 WO2005117941A2 (en) | 2004-04-29 | 2005-04-29 | Methods and compositions for the treatment of polycystic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0510367A true BRPI0510367A (pt) | 2007-11-06 |
Family
ID=35463346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0510367-3A BRPI0510367A (pt) | 2004-04-29 | 2005-04-29 | métodos e composições para o tratamento de doenças policìsticas |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1740221A4 (pt) |
JP (1) | JP2007535562A (pt) |
BR (1) | BRPI0510367A (pt) |
CA (1) | CA2564092A1 (pt) |
MX (1) | MXPA06012446A (pt) |
WO (1) | WO2005117941A2 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1957539T3 (da) | 2005-12-08 | 2013-05-06 | Medarex Inc | Humane monoklonale antistoffer til proteintyrosinkinase 7 (ptk7) og deres anvendelse |
EP1808694A1 (en) * | 2006-01-17 | 2007-07-18 | Universitätsklinikum Freiburg | Method for diagnosing polycystic kidney disease |
ES2402907T3 (es) * | 2006-10-19 | 2013-05-10 | Genzyme Corporation | Roscovitina para el tratamiento de ciertas enfermedades quísticas |
SG196769A1 (en) | 2008-08-25 | 2014-02-13 | Excaliard Pharmaceuticals Inc | Antisense oligonucleotides directed against connective tissue growth factor and uses thereof |
US8946172B2 (en) | 2008-08-25 | 2015-02-03 | Excaliard Pharmaceuticals, Inc. | Method for reducing scarring during wound healing using antisense compounds directed to CTGF |
PL2670411T3 (pl) | 2011-02-02 | 2019-09-30 | Excaliard Pharmaceuticals, Inc. | Związki antysensowne ukierunkowane na czynnik wzrostu tkanki łącznej (ctgf) do leczenia bliznowców lub blizn przerostowych |
JP5995207B2 (ja) * | 2014-11-28 | 2016-09-21 | 学校法人 学習院 | 含ホウ素ポルフィリン誘導体 |
KR102288447B1 (ko) * | 2018-12-28 | 2021-08-10 | 서울대학교산학협력단 | Ctgf 검출용 제제를 포함하는 다낭신의 진단용 조성물 및 이의 이용 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5789189A (en) * | 1993-09-24 | 1998-08-04 | The Regents Of The University Of California | Inhibition of cyst formation by cytoskeletal specific drugs |
US6562618B1 (en) * | 1997-12-25 | 2003-05-13 | Japan Tobacco, Inc. | Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
US6875747B1 (en) * | 1999-05-24 | 2005-04-05 | Avi Bio Pharma, Inc. | Antisense to c-myc for treatment of polycystic kidney disease |
US20030113816A1 (en) * | 2001-09-18 | 2003-06-19 | Weitz Stephen L. | Methods of assaying connective tissue growth factor |
US6965025B2 (en) * | 2001-12-10 | 2005-11-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of connective tissue growth factor expression |
-
2005
- 2005-04-29 BR BRPI0510367-3A patent/BRPI0510367A/pt not_active IP Right Cessation
- 2005-04-29 WO PCT/US2005/014982 patent/WO2005117941A2/en active Application Filing
- 2005-04-29 EP EP05804799A patent/EP1740221A4/en not_active Withdrawn
- 2005-04-29 MX MXPA06012446A patent/MXPA06012446A/es not_active Application Discontinuation
- 2005-04-29 CA CA002564092A patent/CA2564092A1/en not_active Abandoned
- 2005-04-29 JP JP2007511046A patent/JP2007535562A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2005117941A2 (en) | 2005-12-15 |
MXPA06012446A (es) | 2007-01-17 |
WO2005117941A3 (en) | 2006-05-18 |
EP1740221A4 (en) | 2009-01-07 |
EP1740221A2 (en) | 2007-01-10 |
CA2564092A1 (en) | 2005-12-15 |
JP2007535562A (ja) | 2007-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mendes et al. | Lithium reduces Gsk3b mRNA levels: implications for Alzheimer disease | |
Zhang et al. | Endoplasmic reticulum stress: relevance and therapeutics in central nervous system diseases | |
Muneer et al. | Endoplasmic reticulum stress: implications for neuropsychiatric disorders | |
WO2004065576A3 (en) | Methods and compositions for the treatment of urological disorder using differential expressed polypeptides | |
BRPI0306973B8 (pt) | anticorpos anti-igf-ir, seu método de produção e seus usos, hibridoma murino, ácido nucléico isolado, vetor, composição, kit ou conjunto, e método diagnóstico in vitro de doenças induzidas por uma superexpressão ou uma subexpressão do receptor igf-ir | |
WO2007024535A3 (en) | Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders | |
BRPI0509069A (pt) | compostos de imidazol para o tratamento de distúrbios neurodegenerativos | |
WO2009011871A3 (en) | Thiadiazole modulators of pkb | |
JP7212781B2 (ja) | 神経保護剤と組み合わせたsarm1の阻害剤 | |
WO2007046087A3 (en) | Pharmaceutical compositions and diagnostic methods for inflammatory skin disesaes, disorders or conditions | |
Ni et al. | Long-term effects of recurrent neonatal seizures on neurobehavioral function and related gene expression and its intervention by inhibitor of cathepsin B | |
BRPI0510367A (pt) | métodos e composições para o tratamento de doenças policìsticas | |
BRPI0406834A (pt) | Tratamento de doença com agonistas totais do receptor nach alfa-7 | |
Lu et al. | Isoquercetin ameliorates tunicamycin-induced apoptosis in rat dorsal root ganglion neurons via suppressing ROS-dependent endoplasmic reticulum stress | |
Xu et al. | Neuroprotective effects of ebselen are associated with the regulation of Bcl-2 and Bax proteins in cultured mouse cortical neurons | |
Baek et al. | Insulin withdrawal-induced cell death in adult hippocampal neural stem cells as a model of autophagic cell death | |
Wu et al. | PKC isozymes in the enhanced regrowth of retinal neurites after optic nerve injury | |
BRPI0512496A (pt) | processos e composições para o tratamento de doenças policìsticas | |
WO2003073983A3 (en) | Methods and compositions in treating pain using diacylglycerol kinase epsilon | |
WO2003030836A3 (en) | Neuronal regeneration | |
Li et al. | Valproic acid protects neurons and promotes neuronal regeneration after brachial plexus avulsion | |
WO2023091644A3 (en) | Hsd17b13-related double stranded oligonucleotide compositions and methods relating thereto | |
Nakayama et al. | A gain-of-function screen to identify genes that reduce lifespan in the adult of Drosophila melanogaster | |
Bossy et al. | Clearing the brain's cobwebs: the role of autophagy in neuroprotection | |
Robert | Tumors perturbing extracellular matrix biosynthesis. The case of von Recklinghausen's disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |